妇科多剂型产品立项评估数据
收藏资源简介：
一种原料药开发多种制剂剂型在医药发达国家常见的做法，制剂开发集约化，节省原药开发投入，减少污染，节约营销资源投入，延长产品寿命。采集全球范围内医药行业的产品市场信息、注册信息、专利技术信息以及法规信息，结合公司自身技术条件，为企业多剂型产品立项提供多维度情报信息支撑；同时借助大数据分析技术，对相关产品进行全面评估评分，挖掘高价值的目标产品，为制剂产品立项提供精准的线索，提升制剂产品立项工作的效能。妇科多剂型产品立项评估数据算法规则如下：第一，数据处理：从各类商业和官方数据库提取产品市场规模、竞争对手、公司生产线和营销能力配合度、专利门槛等提取多个特征值，并根据多个特征值生成该产品的多个技术指标； 第二，数据算法：采用机器学习技术中的决策树算法对产品进行评分分级，市场规模大于等于20亿得1分，20亿~10亿之间得0.5分，小于10亿不得分。批文数量小于等于5个得1分，高于5个不得分。公司营销领域内得1分，否则不得分。临床一线得0.5分，否则不得分。原料药公司有的得1分，否则不得分。非专利产品得0.5分，专利未过期不得分。产线投资规模低的得0.5分，高的不得分。8项总和得分，高分产品作为立项优选。
It is a common practice in developed pharmaceutical markets to develop multiple dosage forms for an active pharmaceutical ingredient (API). Intensive formulation development can reduce API development investment, cut pollution, save marketing resources, and extend product lifecycle. This dataset collects global pharmaceutical industry data including product market intelligence, registration records, patent technology information and regulatory information, and combines with a company's own technical capabilities to provide multi-dimensional intelligence support for multi-formulation product project initiation. Meanwhile, with the aid of big data analysis technology, it conducts comprehensive evaluation and scoring on relevant products, identifies high-value target products, provides precise clues for formulation product project initiation, and improves the efficiency of formulation project initiation work. The algorithm rules for project initiation evaluation of gynecological multi-formulation products are as follows: 1. Data processing: Extract multiple feature values from various commercial and official databases, including product market size, competitors, alignment between the company's production lines and marketing capabilities, patent barriers, etc., and generate multiple technical indicators for the product based on these feature values. 2. Data algorithm: Adopt the decision tree algorithm in machine learning technology to score and grade products. The specific scoring rules are: 1 point for a market size of ≥ 2 billion USD, 0.5 points for a market size between 1 billion USD and 2 billion USD, and 0 points for a market size less than 1 billion USD; 1 point for the number of regulatory approvals ≤5, and 0 points for >5; 1 point if the product matches the company's marketing field, otherwise 0 points; 0.5 points for first-line clinical application, otherwise 0 points; 1 point if the company is an API manufacturer, otherwise 0 points; 0.5 points for generic products, 0 points for patented products with unexpired patents; 0.5 points for low production line investment scale, and 0 points for high scale. Calculate the total score of the 8 items, and products with high scores are preferred for project initiation.
